One68 Global Capital LLC Buys Shares of 30,951 Kenvue Inc. (NYSE:KVUE)

One68 Global Capital LLC bought a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 30,951 shares of the company's stock, valued at approximately $661,000.

Several other institutional investors and hedge funds also recently made changes to their positions in KVUE. Price T Rowe Associates Inc. MD grew its stake in shares of Kenvue by 3.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company's stock valued at $5,249,665,000 after buying an additional 8,211,748 shares during the last quarter. Vanguard Group Inc. grew its position in Kenvue by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 218,543,705 shares of the company's stock worth $4,665,908,000 after acquiring an additional 1,636,741 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in Kenvue by 12.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 97,661,344 shares of the company's stock worth $2,085,070,000 after purchasing an additional 10,682,003 shares during the period. Geode Capital Management LLC lifted its position in Kenvue by 3.1% in the fourth quarter. Geode Capital Management LLC now owns 46,068,931 shares of the company's stock valued at $980,989,000 after purchasing an additional 1,391,854 shares during the last quarter. Finally, Franklin Resources Inc. boosted its stake in shares of Kenvue by 61.5% during the fourth quarter. Franklin Resources Inc. now owns 42,719,377 shares of the company's stock valued at $912,059,000 after purchasing an additional 16,269,721 shares during the period. Institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently commented on KVUE shares. Redburn Atlantic began coverage on shares of Kenvue in a research note on Thursday, April 10th. They issued a "neutral" rating and a $23.50 target price on the stock. Barclays decreased their price objective on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Monday, April 14th. UBS Group cut their target price on Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. Evercore ISI initiated coverage on Kenvue in a report on Monday, March 24th. They set an "in-line" rating and a $25.00 price target on the stock. Finally, Piper Sandler increased their price objective on Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a report on Monday, February 24th. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, Kenvue has an average rating of "Hold" and a consensus price target of $24.42.

Kenvue Stock Down 1.9 %

NYSE KVUE traded down $0.47 during trading hours on Monday, reaching $23.52. 6,889,765 shares of the company's stock traded hands, compared to its average volume of 16,998,245. The firm has a market cap of $45.12 billion, a PE ratio of 44.40, a PEG ratio of 2.62 and a beta of 1.02. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $24.46. The firm has a 50-day simple moving average of $23.09 and a 200 day simple moving average of $22.52.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Sell-side analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be issued a dividend of $0.205 per share. The ex-dividend date of this dividend is Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.49%. Kenvue's payout ratio is 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.